Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Scleroses, Diffuse”

218 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 218 results

Post-approval studies (Phase 4)WithdrawnNCT01497743
What this trial is testing

Probiotics in Patients With Moderate-to-severe Distention/ Bloating From Systemic Sclerosis

Who this might be right for
Scleroderma
University of Michigan
Testing effectiveness (Phase 2)Study completedNCT03041025
What this trial is testing

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
GlaxoSmithKline 35
Not applicableStudy completedNCT04273386
What this trial is testing

Mouth Handicap in Systemic Sclerosis

Who this might be right for
SclerodermaSystemic SclerosisMouth Diseases
Istanbul University 48
Not applicableStudy completedNCT05617066
What this trial is testing

Stress, Scleroderma and Quality of Life

Who this might be right for
Scleroderma
Asociación Española de Esclerodermia 150
Not applicableStudy completedNCT02494401
What this trial is testing

Taking Charge of Systemic Sclerosis

Who this might be right for
Scleroderma
University of Michigan 267
Testing effectiveness (Phase 2)Looking for participantsNCT07473154
What this trial is testing

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Who this might be right for
Diffuse Cutaneous Systemic SclerosisRheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+1 more
Quell Therapeutics Limited 16
Testing effectiveness (Phase 2)Study completedNCT04137224
What this trial is testing

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring 27
Not applicableStudy completedNCT04411498
What this trial is testing

Effects of Fibromyalgia Syndrome in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisFibromyalgia
Antalya Training and Research Hospital 140
Testing effectiveness (Phase 2)Study completedNCT00442611
What this trial is testing

Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)

Who this might be right for
Scleroderma, DiffuseScleroderma, Systemic
Stanford University 10
Post-approval studies (Phase 4)Study completedNCT04464434
What this trial is testing

Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic SclerosisSystemic Scleroses, DiffuseScleroderma+5 more
UMC Utrecht 60
Not applicableNot Yet RecruitingNCT06373263
What this trial is testing

Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1

Who this might be right for
SclerodermaSystemic Sclerosis
Lady Davis Institute 128
Not applicableStudy completedNCT00074568
What this trial is testing

Scleroderma Registry

Who this might be right for
Systemic SclerosisScleroderma
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 5,000
Large-scale testing (Phase 3)UnknownNCT01586663
What this trial is testing

Serial Night Time Position Splint on Systemic Sclerosis

Who this might be right for
Diffuse Systemic Sclerosis
Federal University of São Paulo 76
Large-scale testing (Phase 3)Study completedNCT00319033
What this trial is testing

Open-label Study With Bosentan in Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseScleroderma
Actelion 132
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Early research (Phase 1)Looking for participantsNCT06801119
What this trial is testing

Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）

Who this might be right for
Systemic Lupus ErythematosusSclerodermaRheumatoid Arthritis
Shenzhen MagicRNA Biotechnology Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT00479934
What this trial is testing

Efficacy and Safety of Imatinib in Scleroderma

Who this might be right for
Scleroderma, LocalizedScleroderma, Systemic
University Hospital, Bordeaux 28
Not applicableUnknownNCT04630782
What this trial is testing

Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease

Who this might be right for
Systemic SclerosisScleroderma
Singapore General Hospital 70
Early research (Phase 1)Study completedNCT00433186
What this trial is testing

Mycophenolate Mofetil in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Boston University 30
Large-scale testing (Phase 3)UnknownNCT05236491
What this trial is testing

COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisAutoimmune Rheumatologic DiseaseSystemic Lupus Erythematosus+6 more
Paul R Fortin 287
Load More Results